The talk will offer an overview of:
- History of OCT application in Cardiology
- A new in vivo diagnosis of plaque erosion in patients with acute heart attack
- A potential major shift in the management of patients with heart attack in the future
Dr. Jang arrived at MGH in 1987 after finishing his clinical training in medicine and cardiology, and receiving PhD at Leuven University in Belgium. Initially, his research focused on the pharmacology and physiology of thrombosis and thrombolysis. Over the years he served as the principal investigator of more than 30 clinical trials including multiple investigator-initiated studies. He pioneered in vivo vascular biology research using OCT in patients with coronary artery disease which began by performing the First-in-human coronary OCT procedure in 1998. In 2010 he established an international OCT Registry, collaborating with more than 25 sites in 9 countries. More than 35 fellows from 10 different countries have trained in Dr. Jang’s laboratory. He has more than 350 publications and has edited three textbooks. In April Dr. Jang will be awarded the “2022 Distinguished Scientist Award” by the American College of Cardiology in recognition of his major scientific contributions to the advancement of scientific knowledge in the field of cardiovascular disease.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.